Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequencing Treatments for Mothers With ADHD and Their At - Risk Children

NCT01816074 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01816074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
Lead sponsor
Seattle Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
May 1, 2017
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder